Addus HomeCare (ADUS) Stock: Buy, Sell, or Hold?
ADUS - Addus HomeCare Corp.
$111.70
1.16 (1.05%)
▲
5d:
-2.06%
30d:
-2.49%
90d:
+6.21%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 02, 2026
30d
Get Alerted When ADUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADUS is fairly valued with market pricing in 0.7% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: ADUS is fairly valued with market pricing in 0.7% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$141.91
Based on 5.3% avg growth
INTRINSIC VALUE TODAY
$88.11
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ADUS is currently trading at $111.70, which is considered oversold relative to its 30-day fair value range of $113.62 to $119.30. The stock's valuation (Forward PE: 14.9) is in line with its historical norms (14.6). At these levels, the market is pricing in 0.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ADUS is in a strong uptrend. The price is currently testing key support at $109.88. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $133.69 (+19.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADUS is in a strong uptrend. The price is currently testing key support at $109.88. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $133.69 (+19.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$113.62 -
$119.30
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($133.69)
- NEUTRAL: Market pricing in 0.7% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (47/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$113.62 -
$119.30
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$109.88
Resistance Level
$118.05
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.88
Wall Street Target
$133.69
(+19.7%)
Revenue Growth (YoY)
8.0%
Earnings Growth (YoY)
24.2%
Profit Margin
7.1%
Valuation Premium vs History
+0.7% premium
PE vs Historical
14.9 vs 14.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.7%
(market-implied from PE analysis)
1-Year Target
$112.48
(+1%)
2-Year Target
$113.27
(+1%)
3-Year Target
$114.06
(+2%)
3-Yr Target (if PE normalizes)
(PE: 15→15)
PE COMPRESSION
$111.95
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 6.6%)
$185.38
(+66%)
Base:
(SPY PE: 14.9, Growth: 6.6%)
$135.18
(+21%)
Bear:
(PE: 12.6, Growth: 6.6%)
$114.90
(+3%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 19.39 | Current EPS (TTM): $5.70
Bull Case
$160.19
(+43%)
Analyst growth 31.7%, PE expands to 21.3
Base Case
$145.62
(+30%)
Market implied 31.7%, PE stable at 19.4
Bear Case
$75.17
(-33%)
Severe decline -20.0%, PE contracts to 16.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 01, 2026 8:43 PM ET
Data refreshes hourly during market hours. Next update: 9:43 PM
Data refreshes hourly during market hours. Next update: 9:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Cliff Donald Blessing
SELL
178 shares
2026-04-21
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 58 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 46 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 45 HOLD |
|
ARDT
Ardent Health Partners, … |
STRONG BUY
11 analysts |
$13 | 58 HOLD |
